.jpg)
.png)
(1).png)
Tune in quarterly and hear from expert speakers to gain insights on some of the leading topics in the field of lipidology. Listen below or download the podcast to listen later.
(3).jpg)
Hosted by:
Alan S. Brown, MD, MNLA
Clinical Associate Professor of Medicine and Cardiology at Loyola Stritch School of Medicine
Director, Division of Cardiology at the Advocate Heart Insitute at Advocate Lutheran General Hospital in Park Ridge, IL
Co-Director of the Cardiology Service Line for Advocate Medical Group/Advocate Health Care
Park Ridge, IL
S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years and Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS
Guest Speakers
Joseph Saseen, PharmD, CLS, MNLA
Professor and Vice Chair Skaggs School of Pharmacy and Pharmaceutical Sciences Associate Dean for Clinical Affairs
University of Colorado
Aurora, CO
Listen to Dr. Brown discuss with Dr. Saseen the Scientific Statement from the NLA and the AGS on managing hypercholesterolemia in adults aged 57 and older who do not have a history of ASCVD.
Additional Materials: Journal Article
S5E4: Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults
Guest Speakers
Daniel E. Soffer, MD, FNLA
Past President, National Lipid Association
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman School of Medicine
Philadelphia, PA
Kevin Maki, PhD, CLS, MNLA
Past President, National Lipid Association
Chief Scientist, Midwest Biomedical Research
Adjunct Professor, Dean’s Eminent Scholar
Indiana University School of Public Health (Bloomington)
Bonita Springs, FL
Listen to Dr. Brown discuss with Dr. Saseen and Dr. Maki about the role of apolipoprotein B in the clinical management of cardiovascular risk in adults.
Additional Materials: Journal Article
S5E3: What’s next for Lipoprotein(a)? Insights from an Expert Discussion Group
Guest Speakers
Marlys L. Koschinsky, Ph.D.
Scientist, Robarts Research Institute
Professor, Dept. of Physiology & Pharmacology
Schulich School of Medicine & Dentistry
The University of Western Ontario London, Ontario, Canada
Jessica M. Pena, MD, MPH, FACC, FNLA
Director, HeartHealth, Dalio Institute of Cardiovascular Imagining
Associate Professor of Clinical Medicine and Medicine in Clinical Radiology
Assistant Dean for Admissions Weill Cornell Medicine and NewYork Presbyterian Hospital
Listen to Dr. Brown discuss with Dr. Koschinsky and Dr. Pena about how this important lipoprotein and potent cardiovascular risk marker is transitioning from the purview of the specialist to that of the general practitioner. Its clinical adoption as an important test is increasing in momentum.
Additional Materials: Journal Article
S5E2: Palisade Phase 3 Data
Guest Speakers
Robert A. Hegele, MD, FRCPC
Director of the Blackburn Cardiovascular Genetics Laboratory
Robarts Research Insitute
London, Ontario
Alan Brown, MD, FNLA talks with Robert A. Hegele MD, FRCP about the Palisade Phase 3 Data
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Guest Speakers
Christie M. Ballantyne, MD, FNLA
Chief, Sections of Cardiology and Cardiovascular Research
Professor of Medicine, Molecular & Human Genetics, and Molecular Physiology & Biophysics
J.S. Abercrombie Chair, Atherosclerosis & Lipoprotein Research
Director, Center for Cardiometabolic Disease Prevention
Baylor College of Medicine
Houston, TX
Alan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"
This page was last updated: Nov 26, 2024